SPYRE THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 2, 2023, a trademark application was filed for SPYRE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SPYRE THERAPEUTICS trademark a serial number of 98251421. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 19, 2024. This trademark is owned by Aeglea BioTherapeutics, Inc.. The SPYRE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders
spyre therapeutics

General Information


Serial Number98251421
Word MarkSPYRE THERAPEUTICS
Filing DateThursday, November 2, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a stylized three-prong antibody design next to the words "SPYRE" in all capital letters and "THERAPEUTICS" in smaller capital letters which is stacked below the word "SPYRE".
Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSPYRE THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02453

Party NameAeglea BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Monday, November 6, 2023NEW APPLICATION ENTERED
Friday, November 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN
Thursday, June 13, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED